This activity is sponsored by
Janssen Pharmaceuticals, Inc. The information contained herein is not intended for continuing medical education (CME) purposes.
April 25, 2019
This activity examines a treatment that may reduce CV events, A1C levels, and systolic BP for patients with type 2 diabetes
.
go to activity»
CMEABIM MOCThere is no commercial support for this activity.
Expiration Date: 4/14/2020
This educational activity will utilize a case study to discuss the management of a 62-year-old man who presents to your office with increasing fatigue, weight loss, and…
go to activity»
CMEABIM MOCThere is no commercial support for this activity.
Expiration Date: 4/14/2020
This educational activity will utilize a case study to discuss the diagnosis and management of a 53-year-old woman with shortness of breath on exertion
.
go to activity»
Raoul Tibes, MD, PhD, is an associate professor in the department of medicine at New York University School of Medicine and director of the clinical leukemia program at…
go to activity»
CMEThis activity is supported by an educational grant from Genentech, Inc.
Expiration Date: 4/11/2020
Anti-VEGF therapy is an important addition to the treatment options for diabetic retinopathy (DR) and is the only medical option that has been granted US Food and Drug…
go to activity»
CMEThis activity is supported by educational grants from Alcon Laboratories, Inc.; Allergan, Inc.; Bausch + Lomb; Kala Pharmaceuticals; and Shire.
Expiration Date: 4/3/2020
Ocular surface disease (OSD) is a group of disorders commonly encountered in ophthalmic practice, but is challenging to diagnose and is often undertreated. However…
go to activity»